Search

Your search keyword '"Antoniou, Christos-Konstantinos"' showing total 244 results

Search Constraints

Start Over You searched for: Author "Antoniou, Christos-Konstantinos" Remove constraint Author: "Antoniou, Christos-Konstantinos"
244 results on '"Antoniou, Christos-Konstantinos"'

Search Results

3. Noninvasive electrocardiographic risk factors for sudden cardiac death in dilated ca rdiomyopathy: is ambulatory electrocardiography still relevant?

4. Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study

6. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis

8. Catheter ablation in grown-up congenital heart disease patients: A single-center experience

9. Health Related Quality of Life and Cardiovascular Risk Factors.

10. Aggressive Rhythm Control Strategy in Atrial Fibrillation Patients Presenting at the Emergency Department: The HEROMEDICUS Study Design and Initial Results

12. Atrial fibrillation: An early marker of ventricular myocardial dysfunction

13. Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study

14. Atrial fibrillation: An early marker of ventricular myocardial dysfunction.

15. Risk assessment of post‐myocardial infarction patients with preserved ejection fraction using 45‐min short resting Holter electrocardiographic recordings

17. Personalized Arrhythmic Risk Stratification for Sudden Cardiac Death in Ischemic, Non-ischemic, and Hypertrophic Cardiomyopathy Patients: The Two-Step, Non-invasive Risk Factors Guiding to Electrophysiology Study Approach

18. Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy

20. Rationale and Design of a Randomized Controlled Clinical Trial on the Safety and Efficacy of Flecainide versus Amiodarone in the Cardioversion of Atrial Fibrillation at the Emergency Department in Patients with Coronary Artery Disease (FLECA-ED)

21. Health Related Quality of Life and Cardiovascular Risk Factors

23. Electrocardiographic Characteristics, Identification, and Management of Frequent Premature Ventricular Contractions.

26. Best Practice Guide for Cryoballoon Ablation in Atrial Fibrillation: The Compilation Experience of More than 1000 Procedures

27. Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: A comparison of three therapeutic protocols

28. Extremely reduced COVID-19 mortality in a “Blue Zone”: an observational cohort study

29. Cardiac involvement in athletes recently recovered from COVID-19

30. Effectiveness and safety of a time to isolation strategy of cryoballoon ablation of atrial fibrillation: A systematic review and meta‐analysis

31. Three‐dimensional electroanatomically guided slow pathway elimination is associated with procedural improvements and clinical benefit in atrioventricular node reentrant tachycardia patients

32. Association of non‐invasive electrocardiographic risk factors with left ventricular systolic function in post‐myocardial infarction patients with mildly reduced or preserved ejection fraction: Insights from the PRESERVE‐EF study

33. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: The Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) Trial

36. ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients : In collaboration with the Council on Stroke, the European Heart Rhythm Association, and the Digital Health Committee

38. Multipoint left ventricular pacing effects on hemodynamic parameters and functional status: HUMVEE single-arm clinical trial (NCT03189368)

39. Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach

40. Permanent pacemaker implantation in unexplained syncope patients with electrophysiology study-proven atrioventricular node disease

42. Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post‐myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE‐EF study

43. Unexplained Syncope: The Importance of the Electrophysiology Study

45. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis

46. Syncope associated with supraventricular tachycardia: Diagnostic role of implantable loop recorders

47. Comparative Trial of the Effects of Left Ventricular and Biventricular Pacing on Indices of Cardiac Function and Clinical Course of Patients With Heart Failure: Rationale and Design of the READAPT Randomized Trial

48. Multipoint left ventricular pacing effects on hemodynamic parameters and functional status: HUMVEE single-arm clinical trial (NCT03189368)

49. Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design – A two-step, multifactorial, electrophysiology-inclusive approach

Catalog

Books, media, physical & digital resources